BioXcel Therapeutics, Inc. (BTAI)
NASDAQ: BTAI · Real-Time Price · USD
2.050
-0.020 (-0.97%)
Dec 12, 2025, 2:24 PM EST - Market open
BioXcel Therapeutics Market Cap
BioXcel Therapeutics has a market cap or net worth of $44.83 million as of December 12, 2025. Its market cap has increased by 97.29% in one year.
Market Cap
44.83M
Enterprise Value
118.38M
1-Year Change
97.29%
Ranking
Category
Stock Price
$2.05
Market Cap Chart
Since March 8, 2018, BioXcel Therapeutics's market cap has decreased from $172.57M to $44.83M, a decrease of -74.02%. That is a compound annual growth rate of -15.93%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Dec 11, 2025 | 45.27M | 143.96% |
| Dec 31, 2024 | 18.56M | -78.51% |
| Dec 29, 2023 | 86.35M | -85.65% |
| Dec 30, 2022 | 601.94M | 5.82% |
| Dec 31, 2021 | 568.84M | -49.47% |
| Dec 31, 2020 | 1.13B | 327.27% |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro |
| Mar 8, 2018 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Eli Lilly and Company | 889.69B |
| Johnson & Johnson | 497.62B |
| AbbVie | 397.98B |
| UnitedHealth Group | 297.45B |
| AstraZeneca | 279.37B |
| Novartis AG | 251.91B |
| Merck & Co. | 242.30B |
| Thermo Fisher Scientific | 215.59B |